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Abstract
Rationale: Prolonged controlled mechanical ventilation results in diaphragmatic inactivity and promotes 
oxidative injury, atrophy, and contractile dysfunction in this important inspiratory muscle. However, the 
impact of controlled mechanical ventilation on global mRNA alterations in the diaphragm remains 
unknown. 
Objectives: In these experiments, we used an Affymetrix oligonucleo-tide array to identify the temporal 
changes in diaphragmatic gene expression during controlled mechanical ventilation in the rat. 
Methods: Adult Sprague-Dawley rats were assigned to either control or mechanical ventilation groups (n 
=5/group). Mechanically venti-lated animals were anesthetized, tracheostomized, and ventilated with room 
air for 6 or 18 h. Animals in the control group were acutely anesthetized but not exposed to mechanical 
ventilation. 
Measurements and Main Results: Compared with control diaphragms, microarray analysis identified 354 
differentially expressed, unique gene products after 6 and 18 h of mechanical ventilation. In general, genes 
in the cell growth/cell maintenance, stress response, and nucleic acid metabolism categories showed 
predominant upregula-tion, whereas genes in the structural protein and energy metabo-lism categories 
were predominantly downregulated. 
Conclusions: We conclude that mechanical ventilation results in rapid changes in diaphragmatic gene 
expression, and subsequently, many of these changes may contribute to atrophy and muscle fiber 
remodeling associated with unloading this primary inspiratory mus-cle. Importantly, this study also 
provides new insights into why the diaphragm, after the onset of contractile inactivity, atrophies more 
rapidly than locomotor skeletal muscles and also highlights unique differences that exist between these 
muscles in the mRNA response to inactivity.
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Rationale: Prolonged controlled mechanical ventilation results in
diaphragmatic inactivity and promotes oxidative injury, atrophy, 
and contractile dysfunction in this important inspiratory muscle. 
However, the impact of controlled mechanical ventilation on global 
mRNA alterations in the diaphragm remains unknown. 
Objectives: In these experiments, we used an Affymetrix oligonucleo- 
tide array to identify the temporal changes in diaphragmatic gene 
expression during controlled mechanical ventilation in the rat. 
Methods: Adult Sprague-Dawley rats were assigned to either control
or mechanical ventilation groups (n = 5/group). Mechanically venti- 
lated animals were anesthetized, tracheostomized, and ventilated 
with room air for 6 or 18 h. Animals in the control group were 
acutely anesthetized but not exposed to mechanical ventilation. 
Measurements and Main Results: Compared with control diaphragms,
microarray analysis identified 354 differentially expressed, unique 
gene products after 6 and 18 h of mechanical ventilation. In general, 
genes in the cell growth/cell maintenance, stress response, and 
nucleic acid metabolism categories showed predominant upregula- 
tion, whereas genes in the structural protein and energy metabo- 
lism categories were predominantly downregulated. 
Conclusions: We conclude that mechanical ventilation results in
rapid changes in diaphragmatic gene expression, and subsequently, 
many of these changes may contribute to atrophy and muscle fiber 
remodeling associated with unloading this primary inspiratory mus- 
cle. Importantly, this study also provides new insights into why the 
diaphragm, after the onset of contractile inactivity, atrophies more 
rapidly than locomotor skeletal muscles and also highlights unique 
differences that exist between these muscles in the mRNA response 
to inactivity. 
Keywords: gene expression; microarray; muscle atrophy; respiratory 
muscle; weaning from mechanical ventilation 
Mechanical ventilation (MV) is used clinically to maintain blood 
gas homeostasis in patients who are incapable of maintaining 
adequate alveolar ventilation on their own. For many of these 
patients, an unfortunate consequence of prolonged MV is the 
ensuing development of respiratory muscle weakness (1). It is 
now clear that prolonged MV is associated with significant atro- 
phy and contractile dysfunction of the diaphragm (2–6). Recent 
animal studies indicate that controlled MV leads to significantly 
greater respiratory muscle weakness than assisted MV (7) be- 
cause controlled MV results in complete loss of neural activation 
and mechanical activity of the diaphragm (3, 7, 8). Therefore, 
controlled MV is a useful physiologic model to investigate the 
effects of prolonged inactivity of the diaphragm (2, 3). 
The diaphragm experiences remarkable physiologic and bio- 
chemical alterations during periods of unloading. The time frame 
of phenotypic changes that the diaphragm undergoes during 
MV occurs on the order of hours (3, 9), whereas diaphragmatic 
inactivity imposed by phrenic nerve denervation and cervical 
spinal cord hemisection occurs over the course of days (10–12). 
Work by our laboratory has demonstrated increased oxidative 
stress (6, 9), decreased rates of protein synthesis (13), and en- 
hanced rates of proteolysis (6, 14), in addition to impaired dia- 
phragm contractility after MV. Importantly, a remarkable dis- 
tinction between atrophy of the diaphragm induced by MV and 
that of locomotor muscle after disuse is the time course of the 
atrophy process. The rapid rate of MV-induced diaphragmatic 
atrophy greatly exceeds the rate of atrophy observed in locomo- 
tor muscles during periods of disuse (i.e., immobilization or hind- 
limb suspension). For example, using the rat as an experimental 
model, the onset of disuse muscle atrophy occurs approximately 
eight times faster in the diaphragm compared with locomotor 
skeletal muscle (6, 15). Therefore, the current study investigated 
the gene expression responses underlying the processes associ- 
ated with the prompt onset of MV-induced diaphragmatic atro- 
phy and muscle fiber remodeling. 
To date, the mechanisms responsible for MV-induced dia- 
phragmatic atrophy, contractile dysfunction, and oxidative injury 
have been studied primarily at the protein level. Only a limited 
number of genes (7, 13, 16–19) have been studied to provide 
insight into the molecular events that occur in the diaphragm 
as a result of MV. Nonetheless, the observed physiologic and 
biochemical diaphragmatic alterations induced by MV are con- 
sistent with the notion that MV results in altered levels of dia- 
phragmatic gene expression. 
Historically, the study of transcriptional changes required 
the analysis of individual mRNA transcripts. However, recent 
advances in biotechnology, including microarray analysis, permit 
the simultaneous measurement of large numbers of gene tran- 
scripts. For example, recent studies have investigated skeletal 
muscle gene expression in response to both hind-limb immobili- 
zation and hind-limb unloading (20–25). However, at present, 
the mRNA alterations that contribute to MV-induced changes 
in the diaphragm are unknown; this forms the rationale for the 
current experiments. The current study used the Affymetrix RG- 
U34A (Affymetrix, Santa Clara, CA) array to investigate the 
effects of controlled MV on gene expression in the diaphragm. 
On the basis of previous studies from our laboratory, we hypoth- 
esized that, compared with control diaphragms, diaphragms 
 
 
exposed to MV would exhibit altered transcript levels for genes 
linked to specific cellular functions associated with the stress 
response, protein metabolism, and calcium regulation. Some of 
the results from these studies have been previously reported in 
the form of an abstract (26). 
 
METHODS 
Animals and Experimental Design 
These experiments were approved by the University of Florida Animal 
Use Committee. Adult (4-mo-old) female Sprague-Dawley rats were 
randomly assigned to either control, 6 h MV (MV6), or 18 h MV 
(MV18; n = 5/group). Animals were killed around the same time 
(± 2 h) of the day to minimize possible influences of circadian rhythm 
on gene expression levels (27). A brief outline of the experimental 
methods follows, with methodologic details for each procedure pro- 
vided in the online supplement. 
 
Protocol for Control Animals 
Control animals were anesthetized with an intraperitoneal injection 
of sodium pentobarbital (50 mg/kg bodyweight). The diaphragm was 
quickly removed and segments from the medial costal diaphragm were 
frozen in liquid nitrogen and stored at –80°C. 
 
Protocol for MV Animals 
All surgical procedures were performed using aseptic techniques. MV 
animals were anesthetized with an intraperitoneal injection of sodium 
pentobarbital (50 mg/kg bodyweight), tracheostomized, and mechani- 
cally ventilated using a volume-driven small-animal ventilator (Harvard 
Apparatus, Cambridge, MA). An arterial catheter was inserted into 
the carotid artery for constant measurement of systolic blood pressure, 
periodic blood sampling, and infusion of isotonic saline. A venous 
catheter was inserted into the jugular vein for continuous infusion of 
sodium pentobarbital (rv 10 mg/kg/h). Body temperature was main- 
tained at approximately 37°C by use of a recirculating heating blanket. 
Heart rate was monitored via a lead II ECG using subcutaneous needle 
electrodes. Animals were administered enteral nutrition using the AIN- 
76 rodent diet (Research Diets Inc., New Brunswick, NJ) and received 
continuous care and monitoring. On completion of MV, the diaphragm 
was quickly removed and segments from the medial costal diaphragm 
were frozen in liquid nitrogen and stored at –80°C. 
 
Isolation of Total RNA 
A portion of the medial costal diaphragm was homogenized in Trizol 
reagent (Invitrogen, Carlsbad, CA) and processed according to the 
manufacturer’s instructions. 
 
Microarray Processing 
Total RNA was prepared for hybridization according to the protocols 
in the GeneChip expression analysis technical manual (Affymetrix). 
 
Reverse Transcription and cDNA Quantification for 
Real-Time Polymerase Chain Reaction 
Reverse transcription was performed using the Superscript III First- 
Strand Synthesis System for reverse transcriptase–polymerase chain 
reaction (PCR; Life Technologies, Carlsbad, CA) followed by cDNA 
quantification (Molecular Probes, Eugene, OR). 
 
Quantitative Real-Time PCR 
Quantitative real-time PCR for hypoxanthine guanine phosphoribosyl- 
transferase, growth arrest and DNA damage–inducible 45 a (Gadd45a), 
and thioredoxin reductase-1 (TxnRd1) was performed using the ABI 
Prism 7000 Sequence Detection System (ABI, Foster City, CA). 
 
Data Analysis 
Microarray images were analyzed using statistically based Affymetrix 
Microarray Suite 5.0 (Affymetrix). In reporting differentially expressed 
genes, we used a conservative approach to the data analysis using the 
following criteria: (1 ) a transcript was required to be present on all 
five chips within any one of the three experimental groups, (2 ) genes 
needed to be significant at p < 0.001, and (3 ) transcripts must have 
displayed at least a ± 1.5-fold change. Changes in mRNA expression 
measured by real-time PCR were assessed with an unpaired Student’s 
t test, with a Bonferonni correction on normalized (hypoxanthine gua- 
nine phosphoribosyltransferase) input values. A p values less than 0.05 
was considered significant. 
 
RESULTS 
Systemic and Biological Response to MV 
Total RNA was obtained from diaphragms of animals included 
in a previously reported study (9). As reported previously, ani- 
mal bodyweights did not differ (p > 0.05) between the control 
(296 ± 5 g), MV6 (pre-MV = 277 ± 6 g; post-MV = 276 ± 5 g), 
or MV18 (pre-MV = 296 ± 15 g; post-MV = 293 ± 14 g) groups. 
These results confirm that our program of enteral nutrition and 
rehydration was adequate. 
To determine if our MV protocol was successful in main- 
taining homeostasis, we measured arterial blood pressure, pH, 
and the partial pressures  of both CO2 and O2 in all animals 
within the first and final hour of MV. Although variations in 
arterial blood pressure, blood gases, and pH existed between 
animals during MV, our data indicate that adequate arterial 
blood pressure and blood gas/pH homeostasis were maintained 
in all animals during MV. As reported previously, systolic blood 
pressure and arterial pH ranged from 95 to 115 mm Hg and 7.42 
to 7.45, respectively (9). 
Because sepsis is associated with diaphragmatic contractile 
dysfunction, strict aseptic techniques were followed throughout 
the experiments. Our results indicate that the animals included 
in our analysis did not develop infections during MV. This state- 
ment is supported by the observation that microscopic examina- 
tion of blood revealed no detectable bacteria and postmortem 
examination of the lungs (visual) and peritoneal cavity (visual) 
displayed no detectable abnormalities. Furthermore, our MV 
animals were afebrile during the investigation. Collectively, 
these results indicate that the MV animals used in our analysis 
were free of significant infection. 
Overview of Microarray Findings 
In these experiments we used the Affymetrix U34A rat chip 
containing 8,799 probe sets that represent unique genes and 
expressed sequence tags. In our data analysis, after the removal 
of probe sets not receiving at least one present call, the number 
of expressed transcripts in the diaphragm was 4,405. Under the 
present criteria, which require five present calls within any one 
of the three experimental groups, the number of expressed tran- 
scripts was reduced to 3,303. Data analysis identified 508 differ- 
entially expressed gene transcripts at the p < 0.001 level. From 
this list of candidate genes, we further identified a subclass of 420 
differentially expressed transcripts (i.e., 354 unique gene products) 
that demonstrated at least a ± 1.5-fold difference in expression. 
Our use of stringent criteria in the data analysis provides a high 
level of confidence in the reported list of differentially expressed 
genes. With our analysis, we opted to use an approach that would 
limit the number of reported false-positives (type I error). 
Quantitative real-time PCR data for two genes (Gadd45a 
and TxnRd1) exhibiting disparate expression patterns are pre- 
sented in Table 1. Importantly, the PCR results for these genes 
showed excellent agreement with the microarray analysis with 
respect to direction and magnitude of change. 
The list of differentially expressed genes was grouped into 
19 functional categories. Because of the number of differentially 
expressed genes, we elected to narrow our discussion to selected 
categories (Tables 2–5). A comparison of differentially expressed 
genes in the inactive diaphragm and the inactive soleus muscle 
 
 
TABLE 1. QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION CONFIRMATION OF 
MICROARRAY  DATA 
 
 
Microarray Real-Time PCR 
 
mRNA Fold* MV6 p Value Fold MV18 p Value Fold MV6 p Value
†
 Fold MV18 p Value
†
 
TxnRd1 ↑ 1.27 8.38E-02 ↑ 3.51 5.42E-06 ↑ 1.22 3.32E-01 ↑ 3.85 1.09E-03 
Gadd45a ↑ 8.28 1.32E-04 ↑ 16.67 4.62E-08 ↑ 6.02 5.15E-03 ↑ 20.30 1.06E-04 
 ↑ 8.01 6.50E-04 ↑ 15.49 5.85E-05  
 ↑ 6.68 1.56E-03 ↑ 13.20 1.94E-05 
 ↑ 6.66 1.76E-03 ↑ 13.14 1.63E-05 
Definition of abbreviations: Gadd45a = growth arrest and DNA damage–inducible 45a; PCR = polymerase chain reaction; 
TxnRd1 = thioredoxin reductase-1. 
* Fold indicates the fold change from control values. 
† 
p Value calculated by Student’s t test on linear, normalized (hypoxanthine guanine phosphoribosyltransferase) input values. 
 
 
is also made in Table 6. Remaining genes not presented in the 
discussion together with the list of expressed sequence tags are 
contained within Tables E1–E8 on the online supplement. 
For nearly all probe sets, a more pronounced fold change 
was observed after 18 h than after 6 h of MV. Only seven genes 
demonstrated a greater fold change at 6 compared with 18 h of 
MV; however, the greatest difference between the two time 
points was only 0.3-fold. In addition, only one gene (peripheral 
myelin protein 22) was differentially expressed ± 1.5-fold at 6 h 
but not at 18 h of MV. 
The list of differentially expressed genes in the following 
discussion was categorized into stress response, protein metabo- 
lism, calcium regulation, or energy metabolism categories. As 
reported previously by our lab group and others, MV leads to 
diaphragm contractile dysfunction, oxidative stress, and atrophy. 
Therefore, we chose to limit our discussion to categories of genes 
with particular relevance to these outcomes. 
DISCUSSION 
Our results support the hypothesis that, compared with control 
diaphragms from spontaneously breathing animals, diaphragms 
exposed to MV exhibit altered transcript levels for numerous 
genes linked with the stress response, protein metabolism, and 
calcium regulation. In addition, we observed significant changes 
in diaphragmatic transcript levels for genes involved in energy 
metabolism. A discussion of our major findings follows. 
Stress-responsive Genes 
Oxidative stress has been implicated as a contributing factor to 
the progression of skeletal muscle atrophy during disuse (14, 
28–31). Importantly, recent work in our laboratory has also 
revealed that oxidative stress in the diaphragm develops within 
the first 6 h of the onset of MV (6, 9). Oxidative stress is likely 
preceded by a disruption in the intracellular redox balance, which 
 
 
TABLE 2. DIFFERENTIAL EXPRESSION OF STRESS-RESPONSE GENES IN THE DIAPHRAGM AFTER 6 AND 18 H OF MECHANICAL 
VENTILATION 
 
 
MV6/Control MV18/Control 
 
  
Affymetrix Probe p Value* Fold
† 
p Value* Fold
† 
Gene Description 
 
L19998_g_at 3.20E-01 -0.9  6.12E-04 -2.8 Sulfotransferase family 1A, phenol-preferring, member 1 Toxilogic response 
M11942_s_at 2.83E-01 0.9  6.26E-04 1.5 Heat shock protein 8 Chaperone 
rc_AI176546_at 1.74E-01 0.9  3.82E-04 2.0 Heat shock protein 86 Chaperone 
M86389cds_s_at 4.09E-02 1.7  3.16E-04 2.6 Heat shock 27-kD protein 1 Chaperone 
rc_AA998683_g_at 3.01E-03 1.8  1.21E-05 2.1 Heat shock 27-kD protein 1 Chaperone 
rc_AI176658_s_at 2.37E-03 1.9  4.70E-04 2.2 Heat shock 27-kD protein 1 Chaperone 
rc_AA998683_at 4.37E-04 2.4  3.29E-04 3.4 Heat shock 27-kD protein 1 Chaperone 
L33869_at 9.20E-02 1.3  4.14E-07 2.4 Ceruloplasmin Trace metal metabolism 
E01415cds_s_at 2.11E-01 -1.9  5.63E-06 -2.7 Glutathione S transferase Toxilogic response 
rc_AI233261_i_at 2.02E-01 1.4  3.85E-04 2.5 Glutamate cysteine ligase, modifier subunit Glutathione synthesis 
AF037072_at 9.37E-02 -1.3  2.91E-04 -2.4 Carbonic anhydrase 3 CO2  disposal 
rc_AI179610_at 3.40E-03 7.6  2.31E-04 18.8 Heme oxygenase 1 Trace metal metabolism 
J02722cds_at 1.09E-02 10.7  9.62E-05 26.5 Heme oxygenase Trace metal metabolism 
rc_AA799678_s_at 2.90E-03 -1.7  6.44E-05 -2.0 EGL nine homolog 3 (C. elegans) Oxygen sensor 
U06713_at 2.54E-04 -1.5  2.93E-05 -2.0 EGL nine homolog 3 (C. elegans) Oxygen sensor 
rc_AI070295_g_at 1.76E-03 6.7  1.63E-05 13.1 Growth arrest and DNA damage–inducible 45a Response to DNA damage stimulus 
L32591mRNA_g_at 1.56E-03 6.7  1.94E-05 13.2 Growth arrest and DNA damage–inducible 45a Response to DNA damage stimulus 
rc_AI070295_at 6.50E-04 8.0  5.85E-05 15.5 Growth arrest and DNA damage–inducible 45a Response to DNA damage stimulus 
L32591mRNA_at 1.32E-04 8.3  4.62E-08 16.7 Growth arrest and DNA damage–inducible 45a Response to DNA damage stimulus 
rc_AI102562_at 7.36E-05 12.6  1.63E-04 21.8 Metallothionein Trace metal metabolism 
M11794cds#2_f_at 6.56E-06 20.9  2.10E-04 25.9 Metallothionein-2 and metallothionein-1 Trace metal metabolism 
Z24721_at 3.33E-02 -1.6  2.36E-05 -3.7 Superoxide dismutase 3 Redox regulation 
rc_AA891286_at 8.38E-02 1.3  5.42E-06 3.5 Thioredoxin reductase-1 Redox regulation 
rc_AI230247_s_at 9.72E-03 -1.4  3.02E-04 -2.3 Selenoprotein P, plasma, 1 Redox regulation 
rc_AA799650_at 1.77E-01 -0.8  9.60E-04 -1.6 Peroxiredoxin 3 Redox regulation 
Definition of abbreviation: EGL = egg-laying defective. 
* p Values calculated by Wilcoxon’s signed rank test. 
† 
Fold indicates the fold change from control values. 
 
 
 
TABLE 3. DIFFERENTIAL EXPRESSION OF PROTEIN METABOLISM GENES IN THE DIAPHRAGM AFTER 6 AND 18 h OF 
MECHANICAL VENTILATION 
 
 
MV6/Control MV18/Control 
 
  
Affymetrix Probe p Value* Fold
† 
p Value* Fold
† 
Gene Description 
 
S61960_s_at 6.95E-02 -0.4  4.02E-04 -1.7 Cysteine conjugate [3-lyase Amino acid derivative metabolism 
J04171_at 4.16E-01 -0.2  1.04E-05 -1.7 Glutamate oxaloacetate transaminase 1 Amino acid metabolism 
rc_AA800318_at 1.28E-01 1.9  4.27E-04 3.0 Serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), Complement activation 
      member 1  
D87515_at 1.29E-03 -1.9  1.87E-05 -2.5 Aminopeptidase B Membrane alanyl aminopeptidase 
L07281_at 2.81E-01 -0.2  3.55E-05 -1.8 Carboxypeptidase E Peptide hormone processing 
rc_AI231547_at 5.80E-01 -0.7  3.67E-04 -1.9 FK506 binding protein 4 (59 kD) Protein folding 
U68544_at 4.71E-01 -0.5  3.83E-04 -2.3 Peptidylprolyl isomerase F Protein folding 
M19533mRNA_i_at 7.91E-01 -0.3  9.37E-04 2.1 Peptidylprolyl isomerase A Protein folding 
rc_AA818858_s_at 4.13E-01 0.5  8.74E-05 2.1 Peptidylprolyl isomerase A (cyclophilin A) Protein folding 
rc_AA818487_s_at 4.40E-01 0.6  5.08E-04 1.6 Cyclophilin B Protein folding 
rc_AA859942_at 1.24E-01 1.3  5.93E-05 1.7 N-myristoyltransferase 1 Protein modification 
M26686_g_at 3.96E-02 -1.1  9.72E-04 -2.1 Protein-L-isoaspartate (D-aspartate) O-methyltransferase1 Protein modification 
rc_AI178828_i_at 7.09E-01 2.1  5.61E-05 4.0 Eukaryotic translation initiation factor 4E binding protein 1 Protein synthesis 
rc_AI639441_at 3.11E-01 0.2  4.03E-04 1.6 Eukaryotic translation initiation factor 2B, subunit 3 Protein synthesis 
U38253_at 1.54E-01 0.7  4.15E-05 1.8 Eukaryotic translation initiation factor 2B, subunit 3 Protein synthesis 
rc_AA892367_i_at 3.39E-01 0.9  2.81E-04 3.0 Ribosomal protein L3 Protein synthesis 
rc_AI013194_at 2.22E-01 0.9  8.02E-04 2.9 Eukaryotic initiation factor 5 (eIF-5) Protein synthesis 
U38253_g_at 5.76E-02 1.1  9.89E-05 1.6 Eukaryotic translation initiation factor 2B, subunit 3 (y, 58 kD) Protein synthesis 
J02646_at 6.53E-02 1.3  1.34E-04 1.5 Eukaryotic translation initiation factor 2, subunit 1 (a) Protein synthesis 
X62166cds_s_at 1.45E-01 1.3  3.68E-05 2.3 Ribosomal protein L3 Protein synthesis 
rc_AI012604_at 2.46E-03 1.3  7.89E-05 1.9 Eukaryotic initiation factor 5 (eIF-5) Protein synthesis 
U05014_g_at 3.74E-03 2.5  2.40E-07 4.0 Eukaryotic translation initiation factor 4E binding protein 1 Protein synthesis 
U05014_at 2.84E-02 2.9  8.42E-05 4.8 Eukaryotic translation initiation factor 4E binding protein 1 Protein synthesis 
AF061726_s_at 3.77E-02 -1.3  8.70E-05 -2.4 Calpain 3 Protein degradation 
M38135_at 2.72E-05 -1.3  8.67E-04 -1.5 Cathepsin H Protein degradation 
AF052540_s_at 1.41E-01 -1.2  6.02E-05 -2.3 Calpain 3 Protein degradation 
J05121_s_at 5.70E-01 -0.5  3.41E-05 -1.9 Calpain 3 Protein degradation 
X82396_at 2.24E-01 1.7  2.57E-04 3.1 Cathepsin B Protein degradation 
S85184_g_at 1.47E-01 2.0  3.55E-08 4.2 Cathepsin L proenzyme Protein degradation 
rc_AI176595_s_at 1.78E-01 2.5  8.06E-05 5.0 Cathepsin L Protein degradation 
S85184_at 1.03E-01 2.8  4.25E-07 6.5 Cathepsin L proenzyme Protein degradation 
D90211_s_at 6.90E-02 1.1  2.99E-04 2.0 Lysosomal membrane glycoprotein 2 Intrinsic lysosomal membrane protein 
X83537_at 2.79E-01 0.5  3.12E-04 2.2 Matrix metalloproteinase 14, membrane-inserted Protein degradation 
rc_AI169327_g_at 1.19E-01 18.0  6.52E-04 66.2 Tissue inhibitor of metalloproteinase 1 Protein degradation 
* p Value calculated by Wilcoxon’s signed rank test. 
† 
Fold indicates the fold change from control values. 
 
 
leads to the altered expression of proteins involved in  redox 
homeostasis.  In  the  present  investigation,  we  observed  several 
alterations in gene expression that are consistent with the notion 
that controlled MV results in redox disturbances in the diaphragm. 
Superoxide dismutase-3 and selenoprotein P, an extracellular 
glycoprotein containing several selenocysteine residues, progres- 
sively declined over the course of MV. In addition, we observed 
a decrease in peroxiredoxin-3 (Prdx3) mRNA in the diaphragm 
during MV. Prdx3 is a mitochondrial member of the Prdx pro- 
teins, which is induced by oxidative stress and possesses antioxi- 
dant properties (32). In contrast, we observed an increase in 
TxnRd1 in the diaphragm during MV. TxnRd1 is a cytosolic 
selenoenzyme that, together with its substrate, thioredoxin, can 
regenerate dehydroascorbate and various proteins inactivated 
by oxidative stress. Moreover, the observed increases in the 
modifier subunit of glutamate cysteine ligase may indicate in- 
creased glutathione synthesis, the principal intracellular non- 
protein thiol and an important antioxidant. 
 
 
TABLE 4. DIFFERENTIAL EXPRESSION OF CALCIUM REGULATION GENES IN THE DIAPHRAGM AFTER 6 AND 18 h OF 
MECHANICAL VENTILATION 
 
 
MV6/Control MV18/Control 
 
  
Affymetrix Probe p Value* Fold
† 
p Value* Fold
† 
Gene Description 
 
M17069_at 9.52E-03 -1.2 4.86E-04 -1.6 Calmodulin 2 Calcium effector 
X13933_s_at 4.10E-01 0.6 5.08E-04 2.0 Calmodulin 1 Calcium effector 
Y09453cds_at 9.69E-03 -1.5 1.11E-04 -2.5 Calcium channel, voltage-dependent, y subunit 1 Calcium ion transport 
M30581_at 1.06E-03 -1.3 1.69E-05 -1.8 ATPase, Ca
++ 
transporting, ubiquitous (SERCA3) Calcium ion transport 
L04684_at 1.39E-01 -0.6 5.64E-04 -1.6 Calcium channel, voltage-dependent, L type, a1S subunit Calcium ion transport 
U33287_at 7.87E-02 -1.3 1.62E-04 -3.7 Calsequestrin 2 Calcium storage 
* p Value calculated by Wilcoxon’s signed rank test. 
† 
Fold indicates the fold change from control values. 
 
 
TABLE 5. DIFFERENTIAL EXPRESSION OF ENERGY METABOLISM GENES IN THE DIAPHRAGM AFTER 6 AND 18 h OF 
MECHANICAL VENTILATION 
 
 
MV6/Control MV18/Control 
 
  
Affymetrix Probe p Value* Fold
† 
p Value* Fold
† 
Gene Description 
 
U00926_g_at 6.30E-01 -0.5 2.82E-04 -1.7 ATP synthase, H+ transporting, mitochondrial F1 
complex, o 
ATP biosynthesis 
U00926_at 8.31E-01 -0.1 9.40E-05 -1.7 ATP synthase, H+ transporting, mitochondrial F1 ATP biosynthesis 
     complex, delta  
D13123_s_at 7.63E-01 0.3 4.83E-05 -1.6 ATP synthase, H+ transporting, mitochondrial F0 ATP biosynthesis 
     complex, subunit c, isoform 1  
rc_AA801286_at 3.22E-02 -0.9 9.43E-04 -1.6 Inositol (myo)-1(or 4)-monophosphatase 1 Carbohydrate metabolism 
AB015433_s_at 3.93E-03 1.7 3.46E-06 2.4 Solute carrier family 3, member 2 Carbohydrate transport 
AF093773_s_at 4.12E-01 -0.1 3.22E-07 -1.7 Malate dehydrogenase 1 Citric acid cycle 
rc_AA892485_at 7.85E-02 -1.0 3.03E-06 -2.3 Dihydrolipoamide acetyltransferase Conversion of pyruvate to acetyl-CoA 
rc_AI170911_at 1.92E-01 1.1 1.53E-04 1.9 Pyruvate dehydrogenase E1 a-like Conversion of pyruvate to acetyl-CoA 
U83880UTR#1_g_at 3.80E-01 -0.5 1.53E-05 -2.4 Glycerol-3-phosphate dehydrogenase 2 Electron transport 
rc_AA875269_at 5.36E-04 -2.1 4.57E-05 -2.0 Stearoyl-coenzyme A desaturase 2 Fatty acid metabolism 
rc_AI044900_s_at 7.02E-02 -1.8 2.21E-04 -3.2 Fatty acid coenzyme A ligase, long chain 2 Fatty acid metabolism 
D90109_at 1.27E-01 -1.4 6.66E-05 -2.8 Fatty acid coenzyme A ligase, long chain 2 Fatty acid metabolism 
S56508_s_at 3.95E-01 -0.7 9.29E-05 -2.5 Fatty acid coenzyme A ligase, long chain 6 Fatty acid metabolism 
U26033_at 1.20E-01 -0.4 2.39E-04 -2.3 Carnitine O-octanoyltransferase Fatty acid metabolism 
J02773_at 2.35E-01 -0.4 1.67E-04 -1.9 Fatty acid binding protein 3 Fatty acid metabolism 
D85189_at 1.52E-01 1.3 3.23E-05 3.3 Fatty acid coenzyme A ligase, long chain 4 Fatty acid metabolism 
rc_AI236284_s_at 3.85E-02 1.3 3.85E-06 2.1 Fatty acid coenzyme A ligase, long chain 4 Fatty acid metabolism 
AJ005046_g_at 2.84E-01 -0.7 8.45E-05 -2.9 Fructose-1,6-bisphosphatase Gluconeogenesis 
X07320_at 2.62E-03 -1.4 2.13E-05 -2.0 Phosphorylase kinase y1 Glycogen degradation 
X15580complete_seq_s_at 9.06E-01 -1.1 2.27E-04 -5.3 6-phosphofructo-2 kinase/fructose 2, Glycolysis 
     6-biphosphatase 1  
S56464mRNA_g_at 1.93E-02 1.4 9.27E-05 1.8 Hexokinase II Glycolysis 
rc_AI169417_s_at 8.69E-02 1.4 6.04E-04 2.5 Phosphoglycerate mutase 1 Glycolysis 
S63233_g_at 4.23E-03 1.4 2.13E-04 2.3 Phosphoglycerate mutase type B Glycolysis 
L11694_at 8.81E-01 0.0 1.25E-04 -1.8 Phosphoglucomutase 1 Glycogen metabolism 
S81497_i_at 7.31E-01 -0.3 7.06E-04 -1.9 Lipase A, lysosomal acid Lipid catabolism 
D88666_at 1.77E-03 2.9 5.84E-05 4.7 Phosphatidylserine-specific phospholipase A1 Lipid catabolism 
rc_AA874813_s_at 1.82E-01 -0.9 9.31E-04 -2.3 mitofusin 2 Mitochondrial fusion 
rc_AI102505_g_at 2.10E-01 -0.8 1.58E-04 -1.8 Cytochrome C oxidase, subunit VIIIa Mitochondrial oxidative 
      phosphorylation 
L48209_s_at 9.83E-01 -0.7 7.14E-05 -2.1 Cytochrome C oxidase, subunit VIIIa Mitochondrial oxidative 
      phosphorylation 
rc_AA799466_at 
 
U42413_at 
6.75E-02 
 
3.33E-02 
-0.6 
 
-0.8 
8.41E-04 
 
4.13E-04 
-1.5 
 
-1.7 
Adenylate kinase 2 
 
5–AMP–activated protein kinase, y1 noncatalytic 
Regulation of adenine nucleotide 
composition 
Energy balance 
     subunit  
L20427_at 4.06E-01 -0.4 2.09E-05 -2.1 Coenzyme q (ubiquinone) biosynthetic enzyme 3 Ubiquinone synthesis 
D10655_g_at 6.87E-01 -0.7 4.57E-06 -2.0 Dihydrolipoamide acetyltransferase Pyruvate metabolism 
D10655_at 4.87E-01 -0.3 3.94E-04 -1.6 Dihydrolipoamide acetyltransferase Pyruvate metabolism 
D28561_s_at 7.06E-01 -0.1 5.19E-05 -2.3 GLUT4 Glucose transporter 
S68135_s_at 2.35E-02 2.9 7.31E-04 10.4 GLUT1 Glucose transporter 
* p Value calculated by Wilcoxon’s signed rank test. 
† 
Fold indicates the fold change from control values. 
 
 
Another protein that exhibits antioxidant properties is car- 
bonic anhydrase III, a soluble protein present in high levels in 
slow-twitch skeletal muscle (33). Carbonic anhydrase III overex- 
pression enhances resistance against H2O2-mediated oxidation 
and apoptosis in skeletal muscle (34). A decrease in carbonic 
anhydrase III mRNA was detected after 18 h of MV. It is possible 
that downregulated carbonic anhydrase III mRNA levels during 
MV may compromise the intracellular antioxidant buffering 
capacity. 
Heme oxygenase-1 (Hmox1, also known as HSP32) and met- 
allothionein were among the 10 most responsive genes to MV. 
Both genes are upregulated by oxidative stress and both proteins 
possess antioxidant properties. Indeed, Hmox1-mediated iron 
release may lead to increased ferritin synthesis and protection 
against iron-mediated oxidative damage (35). Metallothionein 
may act as an antioxidant via the ability to form complexes with 
metals in addition to acting directly as a free radical scavenger 
(36). Several genes of the heat shock protein (HSP) family were 
upregulated in the diaphragm in response to MV. Of these, 
Hmox1 displayed the greatest response followed by HSP27, 
HSP86 (HSP90 family), and HSP8 (HSP70 family). HSPs are 
induced in response to various stressors to help maintain homeo- 
stasis and protect against cell injury and death. 
In summary, our findings are consistent with the concept that 
controlled MV leads to oxidative stress in the diaphragm (6, 9). 
The expression pattern of stress-responsive genes is consistent 
with the notion that nonmitochondrial, intracellular oxidant pro- 
duction is elevated in the diaphragm during MV. 
Protein Metabolism 
Skeletal muscle disuse accelerates protein degradation and thus 
the rate of muscle atrophy. Work from our laboratory has 
demonstrated elevated proteolysis in the diaphragm after MV 
(6, 14). Importantly, changes in the mRNA expression patterns 
 
 
TABLE 6. COMPARISON OF mRNA ALTERATIONS IN THE DIAPHRAGM AFTER 6 AND 18 h MECHANICAL VENTILATION AND 
LOCOMOTOR SKELETAL MUSCLE (SOLEUS) AFTER 12 h HIND-LIMB UNLOADING 
 
 
 
 
 
GenBank 
Diaphragm Locomotor Muscle 
 
  
     MV6/Control MV18/Control Inactivity/Control  
Accession p Value* Fold
† 
p Value* Fold
† 
p Value* Fold
† 
Description 
 
J03969 3.23E-01 0.6 1.02E-04 1.8 5.6E-06 2.0 Nucleophosmin 1 
S74351 2.63E-05 -7.2 2.06E-03 -5.5 5.6E-07 -2.3 Protein tyrosine phosphatase, nonreceptor type 16 
AI639233 
Z12298 
5.54E-01 0.6 6.98E-05 2.0  
6.7E-07 
 
6.1 
Decorin 
Decorin 
X59859     4.0E-06 3.2 Decorin 
X59859     3.2E-05 2.7 Decorin 
L23148 1.04E-04 -2.5 2.15E-03 -2.6 8.9E-07 -2.4 Inhibitor of DNA binding 1, helix-loop-helix protein (splice variation) 
U02553 5.73E-04 -3.3 6.87E-03 -3.1 4.5E-06 -2.5 Protein tyrosine phosphatase, nonreceptor type 16 
L32591 1.56E-03 6.7 1.94E-05 13.2 < 1E-08 2.4 Growth arrest and DNA damage–inducible 45a 
L32591 1.32E-04 8.3 4.62E-08 16.7 2.4E-06 2.0 Growth arrest and DNA damage–inducible 45a 
AF039583 3.12E-04 -5.7 1.07E-04 -18.8 1.3E-06 -2.8 Decay-accelerating factor 
M32167 
L20913 
 
1.04E-01 
 
-0.9 
 
3.34E-04 
 
-1.6 
9.3E-06 -2.0 VEGF 
VEGF 
S85184 1.47E-01 2.0 3.55E-08 4.2 4.4E-07 4.7 Cathepsin L proenzyme 
S85184 
 
U77829 
1.03E-01 
 
2.24E-02 
2.8 
 
2.0 
4.25E-07 
 
1.97E-05 
6.5 
 
3.9 
1.5E-05 
 
4.2E-04 
2.7 
 
2.5 
Cathepsin L proenzyme 
Rattus norvegicus gas-5 growth arrest homolog nontranslated mRNA 
sequence 
       Rattus norvegicus gas-5 growth arrest homolog nontranslated mRNA 
U77829 3.51E-02 2.4 3.36E-05 5.3   sequence 
D42137 2.83E-02 -1.1 9.35E-04 -1.7 1.3E-05 -2.1 Annexin V 
U50736 6.65E-02 16.8 1.91E-06 56.5 2.2E-07 -2.7 Ankyrin-like repeat protein 
AI169370 
V01227 
2.89E-01 0.9 9.12E-04 2.2  
3.3E-07 
 
-2.4 
a-Tubulin 
a-Tubulin 
M86564 9.04E-01 -0.4 3.99E-04 1.9 1.9E-06 -1.6 a-Prothymosin 
X15580 9.06E-01 -1.1 2.27E-04 -5.3 2.6E-06 3.4 6-phosphofructo-2 kinase/fructose 2,6-biphosphatase 1 
S68135 2.35E-02 2.9 7.31E-04 10.4 3.3E-05 -2.1 GLUT1 
S63233 4.23E-03 1.4 2.13E-04 2.3 1.6E-06 -2.1 Phosphoglycerate mutase type B 
L19998 3.20E-01 -0.9 6.12E-04 -2.8 3.3E-07 2.8 Sulfotransferase family 1A, phenol-preferring, member 1 
L19998     1.9E-06 2.5 Sulfotransferase family 1A, phenol-preferring, member 1 
U12187 1.02E-04 12.8 1.52E-05 17.1 3.3E-07 -8.4 ras-related protein 
Definition of abbreviation: VEGF = vascular endothelial growth factor. 
Note that the locomotor skeletal muscle mRNA data are from a previous study (21) using similar methods to the current study. Genes that responded in a similar 
fashion to mechanical ventilation and hind-limb unloading are above the horizontal line and those that responded antithetically are below the line. 
* p Value calculated by Wilcoxon’s signed rank test. 
† 
Fold indicates the fold change from control values. 
 
 
of several proteolytic enzymes in response to MV are consistent 
with these previous observations. Several members of the ca- 
thepsin family of proteases were upregulated in response to 
disuse; however, the contribution of this system to overall prote- 
olysis is considered to be low (37). Calpain-3 (i.e., muscle-specific 
calpain) mRNA decreased in response to MV. It has been specu- 
lated that decreased calpain-3 activity observed during muscle 
disuse may impact skeletal muscle apoptosis and decrease nuclear 
factor-KB activation (38). In addition, matrix metalloproteinase- 
14 mRNA increased in response to 18 h of MV. Degradation 
of the extracellular matrix as a consequence of muscle disuse 
may further compromise myofiber integrity through alterations 
in membrane permeability (39). The largest fold change indi- 
cated on the array (+ 66.2-fold) was for tissue inhibitor of 
metalloproteinase-1 (TIMP-1) mRNA, an inhibitor of several 
matrix metalloproteinases. Increased TIMP-1 protein may indi- 
cate the occurrence of enhanced extracellular matrix remodeling 
(39). 
It is well documented that a contributing factor to skeletal 
muscle atrophy during disuse is the rapid decrease in protein 
synthesis rates (40). In accordance with these data, we have 
recently reported that MV results in decreased protein synthesis 
in the diaphragm after only 6 h that persists through at least 18 h 
of MV (13). Several mRNAs encoding eukaryotic translation 
initiation factors (eIFs) were upregulated in the diaphragm in 
response to MV, including eIF-5, eIF-2a, and eIF-2B. It is inter- 
esting to note that, despite a decreased rate of protein synthesis 
during MV, an increased expression of eIF mRNAs was ob- 
served. In addition, MV was associated with increased ribosomal 
protein L3 mRNA, a 40S ribosomal subunit. Conversely, in- 
creased eIF-4E binding protein 1 was upregulated in response 
to MV, a finding that is consistent with the observed decrease 
in the rate of protein synthesis in the diaphragm during MV (41). 
Overall, the diaphragm may upregulate the protein translation 
capacity after MV. However, increased expression of eIF-4E 
may contribute to the decreased protein synthesis that is actually 
observed after 6 to 18 h of MV (13). 
Calcium Regulation 
Dysregulation of intracellular calcium is considered to be a key 
factor in the progression of skeletal muscle atrophy during disuse 
(28, 42, 43). Intracellular calcium signaling is conveyed largely 
through calmodulin (CALM), a ubiquitous intracellular calcium 
receptor that regulates numerous cellular processes. Five tran- 
scripts, specified by three calmodulin genes (CALM1, CALM2, 
CALM3), encode a single CALM protein in mammals (44). 
In response to MV, differential expression was observed for 
CALM1, which increased, whereas CALM2 decreased. Because 
 
 
CALM transcripts may exhibit differences in their subcellular 
localization, differential expression of the CALM genes may 
reflect a mechanism for the cell to adjust the subcellular redistri- 
bution and thus local regulation of the CALM protein (44). MV 
decreased transcript levels of calsequestrin 2, the cardiac isoform 
of calsequestrin expressed in cardiac and slow-twitch skeletal 
muscle (45). A decreased expression of sarco-endoplasmic reticu- 
lum calcium ATPase-3 mRNA was observed in response to 18 h 
of MV. A decreased ability of the cell to control cytoplasmic 
calcium may contribute to elevations in free calcium levels in 
the cytosol. In addition, mRNA encoding two subunits (a1S 
and y1) of the L-type voltage-dependent calcium channel was 
decreased in response to MV. Although the a1S subunit forms 
the calcium conduction pore and detects voltage changes, the 
role of the y1 subunit is not well understood (46). Decreased 
expression of the L-type calcium channel, particularly of the 
a1S subunit, could adversely affect the transmission of surface 
depolarization, thus leading to impaired excitation-contraction 
coupling and diaphragmatic contractile dysfunction. Also, MV 
decreased the expression of troponin I slow isoform mRNA 
after 18 h, potentially impacting the calcium sensitivity of the 
contractile apparatus (see online supplement). 
MV Alters Energy Metabolism Pathways 
Controlled MV results in  complete  diaphragmatic  inactivity 
(3, 7, 8). Under such conditions, the metabolic requirements of 
the diaphragm are decreased, which likely impacts the rate of 
cellular energy production.  Decreased  mRNA  of  cytochrome 
C oxidase and subunits of the F0 and F1 ATP synthase complex 
were detected after MV. In addition, decreases in glycerol-3- 
phosphate dehydrogenase-2 mRNA levels, a mitochondrial en- 
zyme responsible for the transfer  of  reducing  equivalents  to 
the mitochondria, were also observed. Lack of diaphragmatic 
contractile activity may reduce ATP utilization and explain the 
decreased expression of AMP protein kinase. In addition, MV 
was associated with decreased dihydroxypolyprenylbenzoate 
methyltransferase mRNA, an enzyme involved in  ubiquinone 
synthesis. An additional regulator of mitochondrial ATP produc- 
tion decreased by MV was mitofusin 2 (Mfn2). Repression of 
Mfn2 in cultured myotubes leads to morphologic fragmentation 
of the mitochondrial network and reductions in O2 consumption 
and glucose oxidation (47). Malate dehydrogenase 1, a citric 
acid cycle component, decreased in response to 18 h of MV. 
Thus, diaphragm unloading during MV downregulates mRNA 
expression of several mitochondrial components, possibly in re- 
sponse to a decreased energy demand. 
Several genes encoding enzymes of fat metabolism were af- 
fected during MV, including long-chain fatty acid coenzyme A 
ligase (Facl), carnitine O-octanoyltransferase (COT), fatty acid 
binding protein 3 (FABP3), and stearoyl-CoA desaturase 2. Five 
isoforms of Facl have been identified in rats that demonstrate 
substrate specificity, differences in tissue distribution, and cellu- 
lar location (48). Isoform 4 (Facl4) demonstrated elevated tran- 
script levels, as opposed to isoforms 2 (Facl2) and 6 (Facl6), 
which demonstrated decreased levels after MV. Changes in the 
isoform composition with diaphragm unloading could lead to 
alterations in the regulation of fatty acid entry into synthetic or 
oxidative pathways (49). After 18 h of MV, COT decreased and 
this may result in a reduced ability to oxidize fatty acids in the 
mitochondria. Also, MV was associated with decreased levels of 
FABP3 mRNA, which may affect fatty acid uptake and utilization. 
Downregulation of stearoyl-CoA desaturase-2 after MV may re- 
flect a decrease in lipid synthesis. Collectively, MV appears to 
downregulate lipid uptake and transport and possibly redirect 
fatty acid metabolism from the oxidative to the synthetic pathways. 
Altered mRNA expression of proteins involved in the metab- 
olism of glucose may indicate alterations in the use of this sub- 
strate for energy metabolism. Although GLUT4 mRNA was 
decreased after MV, elevations in the mRNA expression of 
GLUT1 and hexokinase II were observed. In addition, MV 
increased mRNA encoding phosphoglycerate mutase, which 
may result in an enhanced ability to derive reducing equivalents 
from glucose. Conversely, phosphoglucomutase-1 and phosphor- 
ylase kinase, proteins involved in glycogen turnover, were down- 
regulated after MV. It is interesting to note that MV downregu- 
lated two genes involved in a key regulatory step of the glycolysis/ 
gluconeogenesis pathway (fructose-1,6-bisphosphatase and 6-
phosphofructo-2-kinase/fructose-2,6-biphosphatase-1), espe- 
cially since skeletal muscle is not considered to be a major site 
of glucose synthesis. Overall, MV may decrease the energy de- 
mand of the diaphragm and thus alter mRNA expression pat- 
terns of many genes encoding key energy metabolism enzymes. 
Disuse-induced mRNA Alterations in the Diaphragm versus 
Locomotor Skeletal Muscle 
Although several recent studies have used microarray analysis 
to explore alterations in the gene expression profile of atrophying 
skeletal muscles, a meaningful comparison between many prior 
studies and the current investigation is not possible due to experi- 
mental differences in animal models, differing durations of mus- 
cle unloading, and variance in the microarray methods. However, 
a direct comparison between the global mRNA responses of 
soleus and diaphragm muscle to mechanical unloading is now 
possible because we recently completed a locomotor muscle 
study using a very similar experimental design to the current 
study (Table 6) (21). More specifically, the two experiments used 
a similar analysis of Affymetrix microarrays, young adult, female 
Sprague-Dawley rats, and a comparable duration of muscle un- 
loading. Our locomotor muscle study used the hind-limb suspen- 
sion model to mechanically unload locomotor skeletal muscles. 
Hind-limb suspension is a well established model to reduce en- 
ergy demand and contractile activity in hind-limb skeletal mus- 
cles. The present study, coupled with our previous investigation, 
is important because it provides a direct comparison at the geno- 
mic level of differentially expressed genes between the rat dia- 
phragm and soleus muscle during similar durations of mechanical 
unloading. 
Differentially expressed genes common to both the unloaded 
diaphragm and soleus muscles include genes that are not only 
related to atrophy but other functional categories, including cell 
growth and/or maintenance, signal transduction, extracellular 
matrix, energy metabolism, and structural proteins. Several 
genes common to both the unloaded diaphragm and soleus mus- 
cles demonstrated similar changes in both magnitude and direc- 
tion. Most notably, cathepsin L mRNA was augmented in both 
muscles and has been shown to be upregulated in several models 
of muscle atrophy. Also upregulated was decorin, a highly 
abundant proteoglycan found in the extracellular matrix of skele- 
tal muscle, which appears to be regulated by motor neuron– 
stimulated muscle activity (50). Growth arrest–specific 5 is a 
transcript expressed during the growth arrest phase of the cell 
cycle that was upregulated to a similar degree in both the dia- 
phragm and soleus. An additional gene also involved in cell cycle 
arrest is growth arrest and Gadd45a, although more dramatic 
increases were detected in the unloaded diaphragm compared 
with the soleus. In addition, similar changes between the un- 
loaded diaphragm and soleus were also noted for vascular endo- 
thelial growth factor, a mitogen that acts on endothelial cells to 
promote the formation of new blood vessels. Similarly, downreg- 
ulation was also observed with protein tyrosine phosphatase, 
nonreceptor type 16 (dual specificity), in both muscles. Protein 
 
 
tyrosine phosphatases inactivate mitogen-activated protein ki- 
nase signaling by hydrolyzing the phosphate monoesters of tyro- 
sine residues of p38, c-Jun N-terminal kinase, and, in some 
instances, extracellular signal-regulated kinase (51). 
Several genes differentially expressed in both the unloaded 
diaphragm and soleus  responded in a reciprocal fashion. For 
example, six of the eight common genes demonstrated downreg- 
ulated expression in the soleus compared with upregulation in 
the diaphragm. Included in this list was ankyrin-like repeat pro- 
tein, which was the most responsive gene in the list of 354 differ- 
entially expressed transcripts in the unloaded diaphragm. Inter- 
estingly, this gene is also expressed in cardiomyocytes and acts 
as a negative regulator of cardiac-specific gene expression. Addi- 
tional transcripts demonstrating reciprocal expression were 
genes associated with energy metabolism (6-phosphofructo-2 
kinase/fructose 2,6-biphosphatase 1 and phosphoglycerate mutase 
type B), structural proteins (a-tubulin), apoptosis (a-prothymosin), 
stress response (sulfotransferase family 1A), and signal transduc- 
tion  (ras-related  protein). 
Collectively, the observed differences in global gene expres- 
sion between the unloaded diaphragm and soleus muscles are 
consistent with  the reported  differences in the rate of disuse 
muscle atrophy between these two muscles. Furthermore, also 
highlighted by comparisons made between the unloaded dia- 
phragm and soleus are the similar as well as dissimilar alterations 
in gene expression. These comparisons reflect not only how these 
two muscles respond in a similar fashion but also how they 
respond differently to mechanical unloading. Indeed, an assess- 
ment of these two studies provides for the first time a direct 
comparison at the genomic level of differentially expressed genes 
between the rat diaphragm and  soleus muscle during similar 
durations of mechanical unloading. 
Critique of Experimental Model 
Many adult patients requiring MV are maintained on some form 
of pressure-assist MV. To investigate the effects of MV on dia- 
phragmatic gene expression, we chose to  use controlled MV 
because this mode of MV results in no diaphragmatic contractile 
activity and because controlled MV has relevance in several 
clinical situations. For example, controlled MV is used in adult 
patients in numerous circumstances (e.g., drug overdose, spinal 
cord injury, and surgery) and is also commonly used in pediatric 
patients (52). In addition, we  chose  sodium  pentobarbital  as 
the general anesthetic in these experiments because of direct 
evidence that this anesthetic does not negatively impact dia- 
phragmatic atrophy or contractile dysfunction and does not pro- 
mote oxidative injury (3, 5, 6). 
An important consideration in the present experiments is the 
potential impact of the anesthetic on gene expression levels. Our 
decision to use acutely anesthetized animals as controls instead 
of spontaneously breathing animals was based on two main factors. 
First, anesthetized, spontaneously breathing animals can become 
hypoxic and hypercapnic, and develop arterial (respiratory- 
induced) acidosis. Although these factors do not result in im- 
paired diaphragm contractile properties in  vitro, there is the 
potential for these factors to alter gene expression. Second, so- 
dium pentobarbital suppresses respiratory drive and decreases 
alveolar ventilation, resulting in hypoventilation. It follows that 
the hypoventilation results in a significant reduction in the work 
of breathing. Hence, a “perfect” MV control group does not 
exist. Therefore, by comparing MV to acutely anesthetized con- 
trol animals, we are, in effect, reporting the combined effects 
of the anesthetic and diaphragm unloading that are experienced 
during MV. Nonetheless, we strongly believe that this investiga- 
tion provides new and unique insight into the influence of con- 
trolled MV on global gene expression patterns in the diaphragm. 
Conclusions 
This study identified the differential expression of mRNA tran- 
scripts in the diaphragm in response to 6 and 18 h of MV. 
We identified 420 probe sets (i.e., 354 unique gene products) 
displaying at least a ± 1.5-fold change with respect to control 
animals at the p < 0.001 level. Genes could be categorized into 
19 functional categories, of which we chose to focus on five 
categories with relevance to MV-induced diaphragm dysfunc- 
tion. Stress-response genes demonstrated the largest changes, 
which likely illustrate protective adaptations in response to stres- 
sors, including increased oxidant production. Clearly, the data 
contained in these experiments provide further insight into mo- 
lecular adaptations that occur in the diaphragm during controlled 
MV, which ultimately may assist scientists and clinicians in the 
development of countermeasures to retard MV-induced dia- 
phragmatic atrophy and contractile dysfunction. 
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